肥胖中瘦素和瘦素抵抗:当前的证据,机制和未来的方向
Endocrine connections
|September 11, 2025
概括
莱普有效地治疗罕见遗传疾病中的肥胖症,但由于莱普耐药性,通常在常见的肥胖症中失败. 了解耐药机制是开发向肥胖疗法的关键.
科学领域:
- 内分泌学 在内分泌学.
- 代谢过程中的代谢.
- 肥胖问题研究研究
背景情况:
- 莱普是能量平衡的关键阿迪波金.
- 肥胖症的治疗面临着由于勒素耐药性的挑战.
研究的目的:
- 审查关于瘦素在肥胖中的作用的证据.
- 为了探索勒素耐药性的机制.
- 讨论替代肥胖治疗策略.
主要方法:
- 动物研究的综合 (ob/ob,db/db,饮食引起的肥胖).
- 临床数据的分析 (CLD,LRD,脂质变,常见的肥胖症).
- 关于勒素耐药性的分子机制的总结.
主要成果:
- 勒在先天性勒缺乏症 (CLD) 和脂质营养不良方面是有效的.
- 勒素抵抗机制包括信号缺陷和炎症.
- 由于耐药性,丁类比在常见肥胖症中表现出有限的疗效.
结论:
- 勒素耐药性是复杂的,阻碍了其在常见肥胖症中的使用.
- 像MC4R激动剂这样的向疗法显示出有前途.
- 未来的研究应该专注于增强瘦素敏感性和组合疗法.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Insulin: The Receptor and Signaling Pathways
2.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K


